This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration.
ACS omega · 2019
Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity
Journal of Clinical Investigation · 2019
Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential.
BMC cancer · 2017
Latest funding
- $100,000
Oncolytic Virus Immunotherapy for Brain Cancer
CIHR · 2014 · Nominated PI
- $160,000
Chimeric Oncolytic Virus for Brain Cancer Treatment
CIHR · 2013 · Nominated PI
- $105,000
Enhancing the therapeutic efficacy of oncolytic vaccinia virus using functional genomics
CIHR · 2012 · Supervisor
6 publications.
Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration.
Guevara ML, Jilesen Z, Stojdl D, Persano S
Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity
Walsh SR, Bastin D, Chen L, Nguyen A, Storbeck CJ, Lefebvre C, Stojdl D, Bramson JL, Bell JC, Wan Y
Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential.
Tong JG, Valdes YR, Sivapragasam M, Barrett JW, Bell JC, Stojdl D, DiMattia GE, Shepherd TG
Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis.
Tong JG, Valdes YR, Barrett JW, Bell JC, Stojdl D, McFadden G, McCart JA, DiMattia GE, Shepherd TG
Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency.
Muik A, Stubbert LJ, Jahedi RZ, Geiβ Y, Kimpel J, Dold C, Tober R, Volk A, Klein S, Dietrich U, Yadollahi B, Falls T, Miletic H, Stojdl D, Bell JC, von Laer D
Model-based rational design of an oncolytic virus with improved therapeutic potential.
Le Bœuf F, Batenchuk C, Vähä-Koskela M, Breton S, Roy D, Lemay C, Cox J, Abdelbary H, Falls T, Waghray G, Atkins H, Stojdl D, Diallo JS, Kærn M, Bell JC
Oncolytic Virus Immunotherapy for Brain Cancer
Principal investigators: Stojdl, David F
Keywords: Brain Cancer; Immunotherapy; Oncolytic Virus; Therapeutics
Chimeric Oncolytic Virus for Brain Cancer Treatment
Principal investigators: Stojdl, David F
Keywords: Biotherapeutics; Brain Cancer; Cancer Therapy; Commercialization; Manufacturing; Oncolytic Virus; Process Development
Enhancing the therapeutic efficacy of oncolytic vaccinia virus using functional genomics
Principal investigators: Allan, Kristina J
Keywords: Biotherapeutics; Cancer Therapy; Drug Combination Therapy; Functional Genomics; High-Throughput Screen; Host-Virus Interaction; Oncolytic Virus Therapy; Rnai; Tumour Genetics; Tumour Microenvironment
Program Overview: The Terry Fox New Frontiers Program Project in Cancer Research. Canadian Oncolytic Virus Consortium (Dr. John Bell)
Principal investigators: Bell, John C; Bramson, Jonathan L; Diallo, Jean-Simon; Lee, Patrick W; Lichty, Brian D; Mccart, Judith A; Sonenberg, Nahum; Stojdl, David F
Keywords: Anti Tumour Immunity; Cancer Cell Signalling; Cancer Therapeutics; Genetic Engineering; Innate Antiviral Immunity; Oncolytic Virus; Tumour Microenvironment; Tumour Vasculature
Potentiation of the Therapeutic Efficacy of Oncolytic Vaccinia using High-throughput RNAi Technology
Principal investigators: Allan, Kristina J
Keywords: Biotherapeutics; Cancer Therapy; Cellular Pathways; Drug Combination Therapy; Functional Genomics; High-Throughput Screening; Host/Virus Interactions; Molecular Medicine; Oncolytic Virus Therapy; Rnai
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Department of Medicine
- Orthopedic Surgery
- Biochemistry, Microbiology and Immunology
- Other
Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Hesham Abdelbary
Orthopedic Surgery
1 shared papers, latest 2013
Harold Atkins
Department of Medicine
1 shared papers, latest 2013
Jonathan Bramson
Medicine
1 shared papers, latest 2019
Yonghong Wan
Medicine
1 shared papers, latest 2019
Jean-Simon Diallo
Biochemistry, Microbiology and Immunology
1 shared papers, latest 2013
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.